Drug Profile
Bellenamine
Latest Information Update: 15 Feb 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antibacterials; Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 15 Feb 2001 Profile reviewed but no significant changes made
- 10 Sep 1998 No-Development-Reported for HIV-1 infections in Japan (Unknown route)
- 10 Jul 1996 New profile